|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06160 BEONE MEDICINES
Nominal 
182.300 +4.700 (+2.646%) | 2025/12 - Final USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Net Cash from / (used in) Operating Activities | 1,127,580 | (140,631) | (1,157,453) | (1,496,619) | (1,298,723) |
| Net Cash from / (used in) Investing Activities | (276,155) | (548,350) | 60,004 | 1,077,123 | 640,659 |
| Net Cash from / (used in) Financing Activities | 1,059,451 | 193,449 | 416,478 | (18,971) | 3,636,911 |
| Increase / (Decrease) in Cash & Cash Equivalents | 1,910,876 | (495,532) | (680,971) | (438,467) | 2,978,847 |
| Cash & Cash Equivalents at beginning of period | 2,638,747 | 3,185,984 | 3,875,037 | 4,382,887 | 1,390,005 |
| Effect of Foreign Exchange Rate Changes | 60,024 | (51,705) | (8,082) | (69,383) | 14,035 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 4,609,647 | 2,638,747 | 3,185,984 | 3,875,037 | 4,382,887 |
| Remarks: | Real time quote last updated: 06/03/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD 286,933 |
| %Change | -- |
| EPS / (LPS) | USD 0.200 |
| NBV Per Share ($) | USD 2.831 |